CNBX Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Bethesda, MD
SEC filing record 1 source field available
Fiscal year end
31 August
CNBX Pharmaceuticals Inc. has filed 300 SEC EDGAR filings since 09 Jan 2006

SEC filing history

Showing 26-50 of 265 matching filings.

Per page
25
Current page
2
NT 10-Q File 000-52403

EXTENSION

Filing date
15 Apr 2024
Reporting date
29 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
10 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83146

SC 13G/A

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 000-52403

UPLOAD filing

Filing date
29 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-52403

QUARTERLY REPORT

Filing date
12 Jan 2024
Reporting date
30 Nov 2023
Next action
Verify source filing
10-K File 000-52403

FORM 10-K FOR AUG 2023

Filing date
30 Nov 2023
Reporting date
31 Aug 2023
Next action
Verify source filing
10-Q File 000-52403

QUARTERLY REPORT

Filing date
14 Jul 2023
Reporting date
31 May 2023
Next action
Verify source filing
10-Q File 000-52403

QUARTERLY REPORT

Filing date
14 Apr 2023
Reporting date
28 Feb 2023
Next action
Verify source filing
SC 13G File 005-83146

SC 13G

Filing date
06 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52403

CURRENT REPORT

Filing date
08 Feb 2023
Reporting date
31 Jan 2023
Next action
Verify source filing
RW File 333-262856

REGISTRATION WITHDRAWL

Filing date
27 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 000-52403

DEFINITIVE PROXY STATEMENT

Filing date
15 Feb 2022
Reporting date
14 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14C File 000-52403

PRELIMINARY INFORMATION STATEMENT

Filing date
04 Feb 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .